Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.278
-0.002 (-0.68%)
At close: Apr 28, 2026, 4:00 PM EDT
0.276
-0.002 (-0.79%)
Pre-market: Apr 29, 2026, 9:06 AM EDT

Mereo BioPharma Group Revenue

In the year 2025, Mereo BioPharma Group had annual revenue of $500.00K.

Revenue (ttm)
$500.00K
Revenue Growth
n/a
P/S Ratio
88.84
Revenue / Employee
$12,821
Employees
39
Market Cap
44.42M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025500.00K--
Dec 31, 2024---
Dec 31, 202310.00M--
Dec 31, 2022---
Dec 31, 202149.37M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Xilio Therapeutics 43.77M
Plus Therapeutics 5.21M
Nutriband 2.28M
Rallybio 858.00K
Hyperion DeFi 813.46K
Revenue Rankings